We are live on
!
Find out more
AACR
ACR Alpine Capital Research Portfolio holdings
AUM
$6.7B
1-Year Est. Return
33.44%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+33.44%
3 Year Est. Return
+61.38%
5 Year Est. Return
+53.14%
10 Year Est. Return
+201.58%
AUM
$440M
AUM Growth
–
Cap. Flow
+$433M
Cap. Flow
% of AUM
98.52%
Top 10 Holdings %
Top 10 Hldgs %
77.15%
Holding
22
New
22
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$36.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$35.8M |
| 3 |
Vodafone
VOD
|
+$35.1M |
| 4 |
Lockheed Martin
LMT
|
+$34.8M |
| 5 |
Merck
MRK
|
+$34M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.57% |
| 2 | Financials | 17.08% |
| 3 | Technology | 15.69% |
| 4 | Consumer Staples | 13.08% |
| 5 | Industrials | 12.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
JPMorgan Chase
JPM
$930B
| $37.5M | 8.52% |
+710,012
| New | +$36.1M |
|
|
2
Lockheed Martin
LMT
$131B
| $36.9M | 8.4% |
+340,507
| New | +$34.8M |
|
|
3
Johnson & Johnson
JNJ
$624B
| $36.2M | 8.23% |
+421,762
| New | +$35.8M |
|
4
Microsoft
MSFT
$2.83T
| $34.9M | 7.92% |
+1,009,033
| New | +$33.1M |
|
|
5
Vodafone
VOD
$35.1B
| $34.5M | 7.85% |
+1,178,109
| New | +$35.1M |
|
6
Intel
INTC
$504B
| $34.2M | 7.77% |
+1,409,625
| New | +$33.3M |
|
|
7
Merck
MRK
$322B
| $33.8M | 7.68% |
+762,280
| New | +$34M |
|
8
Humana
HUM
$47.4B
| $33.7M | 7.66% |
+399,105
| New | +$31.5M |
|
|
DELL
9
DELISTED
DELL INC
DELL
| $31.2M | 7.09% |
+2,341,753
| New | +$31.7M |
|
10
Berkshire Hathaway Class B
BRK.B
$1.06T
| $26.5M | 6.03% |
+236,834
| New | +$26.1M |
|
11
Sysco
SYY
$39.1B
| $21.6M | 4.92% |
+633,195
| New | +$21.8M |
|
12
Strategic Education
STRA
$1.7B
| $20M | 4.54% |
+409,049
| New | +$20.5M |
|
13
Illinois Tool Works
ITW
$79.7B
| $16.6M | 3.78% |
+240,656
| New | +$16.1M |
|
14
Walmart Inc
WMT
$863B
| $15.7M | 3.56% |
+630,783
| New | +$16.2M |
|
15
VanEck Pharmaceutical ETF
PPH
$939M
| $12.6M | 2.87% |
+277,421
| New | +$12.8M |
|
|
CLMS
16
DELISTED
Calamos Asset Management, Inc.
CLMS
| $11.2M | 2.54% |
+1,061,908
| New | +$11.6M |
|
17
Vanguard Total Stock Market ETF
VTI
$654B
| $912K | 0.21% |
+11,033
| New | +$915K |
|
|
JPM.WS
18
DELISTED
JPMorgan Chase
JPM.WS
| $655K | 0.15% |
+42,000
| New | +$615K |
|
19
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $500K | 0.11% |
+6,239
| New | +$504K |
|
20
Procter & Gamble
PG
$342B
| $245K | 0.06% |
+3,183
| New | +$250K |
|
|
RFP
21
DELISTED
Resolute Forest Products Inc.
RFP
| $184K | 0.04% |
+14,000
| New | +$208K |
|
Similar funds
MSE
MIP
FLPIM
BHM
SPS
SPC
TAM
TB
ACR Alpine Capital Research's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for ACR Alpine Capital Research, which disclosed 22 positions worth $440M. Its ten largest holdings account for 77% of the portfolio.
Its largest position is JPMorgan Chase: 710,012 shares worth $37.5M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- ACR Alpine Capital Research's largest Q2 2013 buy was JPMorgan Chase: 710,012 shares worth $37.5M.
- ACR Alpine Capital Research's ten largest holdings make up 77% of its $440M portfolio in Q2 2013.
- ACR Alpine Capital Research disclosed 22 positions in Q2 2013, its first 13F filing on record.
Based on ACR Alpine Capital Research's 13F filing for Q2 2013, filed 15 Aug 2013.